Among active 13F managers last quarter, none opened or added and 1 reduced; the largest holder to move was Tower Research Capital LLC (TRC) (−59%). No open-market insider trades in the last 180 days.
0 adding vs 1 trimming; no open-market insider net.
9 tracked 13F filers disclose a position in HCTI as of the latest SEC 13F filings, a combined $219K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 41K | $110K | ▲+434% Added · +33K sh | Q1 2026 | |
| 2 | Morgan Stanley | 20K | $55K | ▲512× Added · +20K sh | Q1 2026 | |
| 3 | Geode Capital Management, LLC | 12K | $22K | ▼−4.9% Reduced · −620 sh | Q2 2026 | |
| 4 | Bank Of Montreal | 10K | $27K | ▲New +10K sh | Q1 2026 | |
| 5 | Vanguard Capital Management LLC | 859 | $2K | →New filer Inherited book · not a new buyer | Q1 2026 | |
| 6 | Tower Research Capital LLC (TRC) | 794 | $2K | ▼−59% Reduced · −1K sh | Q1 2026 | |
| 7 | Vanguard Fiduciary Trust Co | 482 | $1K | →New filer Inherited book · not a new buyer | Q1 2026 | |
| 8 | BNP Paribas Financial Markets | 7 | $19 | ▼−98% Reduced · −393 sh | Q1 2026 | |
| 9 | Danske Bank A/s | 1 | $2 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, no active manager opened or added to a position in HCTI, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| INVESCO QQQ TRUST SERIES 1QQQ | 1 funds | $139.5M |
| DIREX DAIL SEMI BU 3X ET-USDSOXL | 1 funds | $114.1M |
| APPLE INCAAPL | 1 funds | $112.2M |
| MICROSOFT CORPMSFT | 1 funds | $93.6M |
| MICRON TECHNOLOGY INCMU | 1 funds | $90.9M |
| TESLA INCTSLA | 1 funds | $69.2M |
| NVIDIA CORPNVDA | 1 funds | $65.6M |
| BROADCOM INCAVGO | 1 funds | $55.4M |
| ALPHABET INC-CL AGOOGL | 1 funds | $48.7M |
| ISHARES CORE U.S. AGGREGATEAGG | 1 funds | $39.7M |
| SS SPDR S&P 500 ETF TRUST-USSPY | 1 funds | $35.2M |
| VANECK PHARMACEUTICAL ETFPPH | 1 funds | $31.6M |
Ranked by how many of HCTI's institutional holders also hold each name, a cross-fund conviction signal.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Latest quarterly filings | 2 | 3 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital DISCLOSED rotating, as of the latest public SEC 13F filings. It is DATA, NOT investment advice, a recommendation, or a prediction. Filings lag ~45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for HCTI
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HCTI/capital-change-brief"
Use Arkolith's capital_change_brief for HCTI. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for HCTI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.